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Carpal Tunnel Syndrome and Peripheral Polyneuropathy  
in Patients with End Stage Kidney Disease 
This study was designed to identify the causes of the development of carpal tunnel 
syndrome (CTS) associated with end stage kidney disease (ESKD). A total of 112 patients 
with ESKD, 64 on hemodialysis (HD) and 48 on peritoneal dialysis (PD), were enrolled. The 
duration of ESKD and dialysis, the site of the arteriovenous (A-V) fistula for HD, laboratory 
data such as blood urea nitrogen, creatinine, and beta-2-microglobulin were determined. 
Clinical evaluation of CTS and electrophysiological studies for the diagnosis of CTS and 
peripheral neuropathy were performed. The electrophysiological studies showed that the 
frequency of CTS was not different in the HD and PD groups (P = 0.823) and the frequency 
of CTS was not different in the limb with the A-V fistula compared to the contralateral 
limb (P = 0.816). The frequency of HD and PD were not related to beta-2-microglobulin 
levels, an indicator of amyloidosis. The frequency of CTS did not increase as the severity of 
the peripheral neuropathy and the duration of ESKD and dialysis increased (P = 0.307). The 
results of this study do not support that microglobulin induced amyloidosis or placement 
of an A-V fistula are associated with an increase in CTS.
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Neuropathy is a common complication of end stage kidney dis-
ease (ESKD), typically presenting with a distal symmetric pat-
tern with greater involvement of the lower extremities compared 
to the upper extremities (1). However, in addition to the distal 
symmetric peripheral neuropathy (PN), mononeuropathies have 
been reported to occur with increased frequency in patients with 
ESKD, and most typically affect the median, ulnar, and femoral 
nerves (2). Carpal tunnel syndrome (CTS) is the most common 
mononeuropathy in patients with ESKD with a frequency of 8% 
to 31% (3, 4). Microglobulin amyloidosis has been reported as 
the major cause of the development of CTS (5). Amyloid depos-
its have been identified in synovial specimens from dialysis pa-
tients with CTS. In addition, there is an increase in the frequen-
cy of CTS associated with increasing durations of hemodialysis 
(HD) (5). Other factors proposed as causes of CTS include: ure-
mic tumoral calcinosis (6) and placement of an arteriovenous 
(A-V) fistula inducing diversion of blood from the distal limbs 
(7, 8). In a recent study (9), the frequency of CTS was 30.5% in 
the limbs with a fistula and 12.2% in the contralateral limb. How-
ever, the exact causes of the development of CTS in ESKD are 
not known. In addition, many prior studies did not perform elec-
trophysiological studies for the diagnosis of CTS and did not con-
sider the differential diagnosis for coexisting PN and CTS.
  This study was designed to identify the mechanisms of the de-
velopment of CTS using electrophysiological studies in patients 
with ESKD.
MATERIALS AND METHODS
One hundred twelve patients with ESKD were prospectively 
evaluated for CTS. Sixty four patients were on HD and 48 were 
on peritoneal dialysis (PD). There were 34 females and 30 males 
with a mean age of 57.8 ± 13.0 (range: 24-78 yr) in the HD group 
and 23 females and 25 males (mean age, 52.7 ± 12.4; range, 25-
79 yr) in the PD group. Exclusion criteria were: 1) a history of 
fracture or trauma of an upper limb that could cause focal nerve 
injury, 2) metabolic disease other than diabetes mellitus, 3) pa-
tients that could not tolerate electrical stimulation. 
  Data on the duration of ESKD and dialysis, site of the A-V fis-
tula in the patients on HD and additional medical illness were 
noted after review of the medical records. In addition, laboratory 
data such as blood urea nitrogen, creatinine, and beta-2-micro-
globulin were recorded. Clinical evaluation included the symp-
toms and signs of CTS and electrophysiological studies for diag-
nosis of CTS and PN were performed in less than 2 weeks after 
the laboratory examinations. The clinical and electrophysiolog-
ical evaluations were conducted by two experienced physiatrists. 
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ness of lateral four fingers, pain and stiffness of the hands were 
assessed. Muscle strength of the abductor pollicis brevis (APB), 
sensory impairment of median nerve distribution, and the Tinel’s 
sign and Phalen test were assessed objectively. The patients who 
had more than two symptoms and/or signs of five (numbness of 
lateral four fingers, APB weakness, hypesthesia of median nerve 
distribution, Tinel sign, Phalen test) were considered to have ‘clin-
ical CTS’. The patients who also had numbness and hypesthe-
sia of little finger and those revealed the provocative tests only 
were not diagnosed with clinical CTS. 
  Nerve conduction studies were performed using a Counter-
point MK2 (Dantec, Copenhagen, Denmark). The median, ul-
nar, peroneal, and tibial motor nerves and median, ulnar, and 
sural sensory nerves were evaluated using standard conduction 
techniques. The distance between the recording electrode and 
stimulation was 8 cm in all of the compound muscle action po-
tential (CMAP) recordings and was 14 cm for the sensory nerve 
action potential (SNAP) recordings. The F waves of all the motor 
nerves and the H reflex were also evaluated. Skin temperature 
was maintained at 32°C or above in the upper extremity nerves 
and 30°C or above in the lower extremity nerves. PN was diag-
nosed and graded I to IV based on the criteria of our laboratory, 
a modification of the diabetes control and complication trial 
(DCCT) research group (10). CTS was diagnosed when the find-
ings met at least one of the following regardless of the presence 
or absence of a PN: 1) ratio of median sensory latency of a 7 cm 
wrist segment to a 7 cm palm segment > 2.0, 2) ratio of distal la-
tency of a median SNAP to that of an ulnar SNAP > 1.2, 3) ratio 
of the amplitude of a median sensory SNAP with wrist stimula-
tion to that with palm stimulation < 0.5, 4) ratio of the distal la-
tency of a median CMAP to an ulnar CMAP > 1.5, 5) ratio of the 
amplitude of a median CMAP to an ulnar CMAP < 0.6. These cut 
off values are obtained from the 50 healthy volunteers aging from 
26 to 75 (mean age, 55.2 ± 12.0 yr).
Statistical analysis 
The frequency of CTS was compared between PD and HD groups 
using the chi-square test. The correlation between beta-2-mi-
croglobulin levels and the duration of ESKD was analyzed; the 
levels of beta-2-microglobulin were analyzed using the indepen-
dent t-test. The software used for statistical analysis was SPSS 
12.0 (SPSS Inc., Chicago, IL, USA) and the significance level was 
set at a P < 0.05. 
Ethics statement
The health service human research ethics committee and the 
committee on experimental procedures involving human sub-
jects of the Korea University Medical Center reviewed and ap-
proved this study protocol. Informed consent to the procedure 
was obtained from all participants.
RESULTS 
The mean duration on HD and PD was 45.6 ± 41.9 and 59.4 ± 44.7 
months, respectively. The duration of dialysis, BUN, creatinine, 
potassium, and uric acid were not significantly different between 
HD and PD groups. On clinical evaluation, 18 patients were cat-
egorized as having clinical CTS in the patients on HD and 11 in 
patients on PD. Based on the electrophysiological studies, 42 out 
of 64 patients on HD were classified with a PN and/or CTS; 22 
with a PN only, 8 with CTS only; and 12 with both. Among the 
48 patients on PD a PN developed in 16, CTS in 4, and both in   
8 (Table 1). The frequency of CTS was not different in compari-
sons between the HD and PD groups (P = 0.823). Among the pa-
tients with ‘clinical CTS’, three in the HD group and four in the 
PD group had no electrophysiological abnormalities; the other 
patients were electrophysiologically diagnosed with CTS and/or 
a PN (Table 2). The frequency of CTS was not different between 
the limb with an A-V fistula and the contralateral limb (Table 3) 
(P = 0.816). The duration of ESKD, dialysis and beta-2-micro-
globulin levels were not significantly different between the CTS 
group and non-CTS group (Table 4). 
Table 1. Electrophysiologic diagnosis according to the type of dialysis (N = 112)
Diseases HD PD Total (%) P value
Normal  22 20 42 (37.5)
PN  22 16 38 (33.9)
CTS   8   4 12 (10.7) 0.823
CTS + PN  12   8 20 (17.9)
Total  64 48 112 (100.0)
HD, hemodialysis; PD, peritoneal dialysis; PN, peripheral neuropathy; CTS, carpal tun-
nel syndrome.
Table 2. Electrodiagnosis and clinical evaluation in patients on hemodialysis 
Type of dialysis Electrodiagnosis
Number of symptoms/signs
0 1 2 ≥ 3








































HD, hemodialysis; PD, peritoneal dialysis; CTS, carpal tunnel syndrome; PN, periph-
eral neuropathy.
Table 3. Frequencies of CTS according to the side of fistula in patients on hemodialysis
Type
Side of  
A-V fistula
Side of CTS P 
value Right Left Bilateral
A-V fistula Right (n = 2)








Venous catheter Right (n = 0)








A-V, arteriovenous; CTS, carpal tunnel syndrome.Kwon H-K, et al.  •  Carpal Tunnel Syndrome in End Stage Kidney Disease
http://jkms.org   1229 http://dx.doi.org/10.3346/jkms.2011.26.9.1227
DISCUSSION
The development of uremic neuropathy has been related previ-
ously to the retention of neurotoxic molecules in the middle mo-
lecular range. Nerves of uremic patients have shown to exist in 
a chronically depolarized state prior to dialysis, with subsequent 
improvement and normalization of resting membrane poten-
tial after dialysis. The degree of depolarization correlates with 
serum potassium, suggesting that chronic hyperkalemic depo-
larization plays an important role in the development of nerve 
dysfunction in ESKD (1).
  Patients with ESKD frequently complain of a numbness and 
tingling sensation of the hands and feet. The potential causes of 
these symptoms are numerous. Distal symmetric PN may cause 
symptoms more frequently in the feet; the symptoms in the up-
per extremity may be caused by an A-V fistula or mononeuropa-
thies. Recently, mononeuropathies in patients on dialysis, caused 
by entrapment at sites that are physiologically prone to stenosis, 
has become a topic of interest, such as ulnar neuropathy at the 
elbow and median neuropathy at the carpal tunnel (11, 12). How-
ever, the etiology remains unknown and the frequency varies 
widely according to the criteria and methods used for the diag-
nosis. 
  In a report on the association between CTS and A-V fistulas 
in patients on HD (13), clinical CTS was more frequently diag-
nosed in the wrist with an A-V fistula; however, electrodiagnos-
tic studies did not indicate any significant association between 
the frequency of CTS and the A-V fistula or its duration. Such re-
ports raise questions about the validity of electrodiagnostic re-
sults in patients with an A-V fistula, because of the discrepancy 
between the clinical and electrodiagnostic findings. However, 
only median and ulnar motor conduction studies were performed 
for the diagnosis of CTS. In this study, precise criteria for the di-
agnosis of PN and CTS, with or without a PN, were used. The fre-
quencies of clinical and electrodiagnostic CTS were similar: 24/ 
4, 20/64 and 13/48, 12/48 in the HD and PD groups, respective-
ly. However, there was some discrepancy between the clinical 
and electrophysiological diagnosis; the patients with clinical CTS 
had PN due to ESKD but some of the patients diagnosed elec-
trophysiologically were asymptomatic. The electrophysiological 
findings are more objective than the clinical symptoms and/or 
signs; the clinical findings of PN can be due to ESKD even with 
normal electrodiagnostic findings. Therefore, we investigated 
the frequency and correlation of CTS with the clinical variables 
based on the electrodiagnosis. 
  A prior study found no difference in the frequency of CTS in 
patients undergoing PD or HD (14). Similarly, the electrodiag-
nostic confirmation of CTS was not associated with the type of 
dialysis in this study. Many investigators have reported a positive 
correlation between the frequency of CTS and the duration of 
HD (3, 5), and have also reported that the side of the A-V fistula 
could affect the frequency of CTS (12, 13). However, the results 
of this study do not reveal the relationship between the frequen-
cy of electrodiagnostic CTS and the duration of ESKD, dialysis, 
and the side of the A-V fistula. These differences could be ex-
plained by the fact that most of the prior investigators used the 
clinical findings only for the diagnosis of CTS. 
  Since both PN and CTS can cause pain and/or numbness of 
the hands, the differentiation of the two entities is important in 
the management of patients. We used separate electrodiagnos-
tic criteria to diagnose the PN and the CTS, because ESKD can 
induce uremic neuropathy. We also investigated the frequency 
of CTS according to the severity of the PN, and found no signifi-
cant association. This might in part be due to the difficulty in the 
differentiation of the two entities in severe cases with a PN.
  The effect of cervical complications such as spondyloarthrop-
athy, common in patients on long term HD, can induce cervical 
radiculopathy or myelopathy (15). These factors are also an im-
portant consideration in patients with symptoms and/or signs 
without evidence of CTS or a PN. We performed nerve conduc-
tion studies without needle electromyography in this study, to 
avoid patient discomfort, the cases with clinical CTS and nor-
mal electrophysiological findings might have had a cervical ra-
diculopathy. 
  In the reports on patients receiving long-term HD, the fre-
quency of beta-2-microglobulin related osteoarthropathy in-
creased steadily with the length of survival, and the frequency of 
CTS increased with the number of years on dialysis (5). Another 
investigation on patients undergoing HD reported no correla-
tion between CTS and the site of vascular access and synovial 
biopsy of the flexor tendons demonstrated edema without in-
flammation. These findings suggest that extracellular fluid vol-
ume excess in the presence of flexion and immobility during di-
alysis may be important to the pathogenesis rather than osteo-
arthropathy (16). In this study, we did not find an association be-
tween the frequency of CTS and the level of beta-2-microglob-
ulin or between the side of A-V fistula and the development of 
CTS. In this investigation, we considered the effect of diabetes 
mellitus on PN and/or CTS in patients with diabetes and ESKD. 
We also analyzed the patients without diabetes mellitus sepa-
rately, however, the results neither revealed the correlations be-
tween the variables. We do not think that the development of 
CTS in patients with preexisting uremic peripheral neuropathy 
Table 4. Differences between patients with/without carpal tunnel syndrome
Kidney disease CTS Non-CTS P value
Duration of ESKD (months)   78.1 ± 62.26 65.8 ± 51.8 0.307
Duration of HD (months) 55.1 ± 38.7 41.4 ± 43.0 0.849
Duration of PD (months) 76.2 ± 61.7 53.5 ± 36.6 0.059
Beta-2-microglobulin (mg/L) 36.8 ± 14.2 33.9 ± 14.5 0.923
CTS, carpal tunnel syndrome; ESKD, end-stage kidney disease; HD, hemodialysis; PD, 
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AUTHOR SUMMARY
Carpal Tunnel Syndrome and Peripheral Polyneuropathy in Patients with End Stage 
Kidney Disease 
Hee-Kyu Kwon, Sung-Bom Pyun, Won Yong Cho and Chang Su Boo
Neuropathy is a common complication of end stage kidney disease (ESKD), and carpal tunnel syndrome (CTS) is most common. 
This study was designed to identify the mechanisms of the development of CTS in patients with ESKD. The electrophysiological 
studies do not support that microglobulin induced amyloidosis or placement of an A-V fistula are associated with an increase in 
CTS. The cause of CTS in patients with ESKD is supposed to be a vulnerability of nerves for the development of entrapment 
neuropathy in the cases with preexisting peripheral neuropathy.
is a special condition, but rather think that the patients with gen-
eralized peripheral neuropathy are prone to the development 
of entrapment neuropathy.
  Bicknell et al. (4) reported that nerve dysfunction was indepen-
dent of the disease underlying renal failure, the side of dialysis 
access shunt, and the presence or absence of osteodystrophy. 
They recommended that dialysis patients need frequent nerve 
conduction studies from the beginning of dialysis to identify CTS 
early and to avoid irreversible nerve damage. In a report on the 
management of patients with entrapment neuropathy, surgical 
intervention successfully relieved all symptoms, but return of 
normal renal function does not reverse the problem (12). Based 
on the results of previous recommendations and investigations 
on the management of entrapment neuropathy in patients with 
ESKD, early and accurate diagnosis of CTS is important in plan-
ning the treatment of such patients. 
  In conclusion, the results of this study do not support that mi-
croglobulins, involved in the development of amyloidosis, and 
placement of an A-V fistula, are associated with the develop-
ment of CTS in patients with ESKD. 
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